Becton Dickinson and Company

238.25+2.07+0.88%Vol 1.50M1Y Perf -5.84%
Dec 1st, 2023 16:00 DELAYED
BID232.50 ASK241.50
Open236.07 Previous Close236.18
Pre-Market- After-Market238.25
 - -  - -%
Target Price
265.56 
Analyst Rating
Moderate Buy 1.58
Potential %
11.46 
Finscreener Ranking
     39.67
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     41.18
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★     44.26
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
     29.46
Price Range Ratio 52W %
16.41 
Earnings Rating
Strong Sell
Market Cap69.19B 
Earnings Date
9th Nov 2023
Alpha-0.00 Standard Deviation0.06
Beta0.56 

Today's Price Range

235.34238.50

52W Range

228.62287.32

5 Year PE Ratio Range

32.50632.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-1.13%
1 Month
-6.94%
3 Months
-15.18%
6 Months
-4.81%
1 Year
-5.84%
3 Years
-0.69%
5 Years
-6.56%
10 Years
125.50%

TickerPriceChg.Chg.%
BDX238.252.07000.88
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
Financial StrengthValueIndustryS&P 500US Markets
0.40
1.00
0.35
0.64
5.50
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
44.90
12.80
24.10
7.80
8.21
RevenueValueIndustryS&P 500US Markets
13.88B
48.81
2.12
10.10
DividendsValueIndustryS&P 500US Markets
1.44
3.64
4.04
3.27
Payout ratio57.00
Earnings HistoryEstimateReportedSurprise %
Q03 20232.892.962.42
Q02 20232.752.864.00
Q01 20232.672.9811.61
Q04 20222.732.750.73
Q03 20222.492.666.83
Q02 20222.983.186.71
Q01 20222.863.6427.27
Q04 20212.432.596.58
Earnings Per EndEstimateRevision %Trend
12/2023 QR2.46-19.87Negative
3/2024 QR3.01-4.75Negative
9/2024 FY12.84-5.10Negative
9/2025 FY14.28-4.99Negative
Next Report Date-
Estimated EPS Next Report3.42
Estimates Count10
EPS Growth Next 5 Years %9.70
Volume Overview
Volume1.50M
Shares Outstanding290.41K
Shares Float268.33M
Trades Count31.13K
Dollar Volume357.01M
Avg. Volume1.65M
Avg. Weekly Volume1.85M
Avg. Monthly Volume1.80M
Avg. Quarterly Volume1.29M

Becton Dickinson and Company (NYSE: BDX) stock closed at 236.18 per share at the end of the most recent trading day (a 0.21% change compared to the prior day closing price) with a volume of 2.85M shares and market capitalization of 69.19B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 72000 people. Becton Dickinson and Company CEO is Thomas E. Polen.

The one-year performance of Becton Dickinson and Company stock is -5.84%, while year-to-date (YTD) performance is -7.13%. BDX stock has a five-year performance of -6.56%. Its 52-week range is between 228.615 and 287.32, which gives BDX stock a 52-week price range ratio of 16.41%

Becton Dickinson and Company currently has a PE ratio of 44.00, a price-to-book (PB) ratio of 2.92, a price-to-sale (PS) ratio of 5.17, a price to cashflow ratio of 28.30, a PEG ratio of 4.54, a ROA of 3.43%, a ROC of 4.85% and a ROE of 7.45%. The company’s profit margin is 8.21%, its EBITDA margin is 24.10%, and its revenue ttm is $13.88 Billion , which makes it $48.81 revenue per share.

Of the last four earnings reports from Becton Dickinson and Company, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $3.42 for the next earnings report. Becton Dickinson and Company’s next earnings report date is -.

The consensus rating of Wall Street analysts for Becton Dickinson and Company is Moderate Buy (1.58), with a target price of $265.56, which is +11.46% compared to the current price. The earnings rating for Becton Dickinson and Company stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Becton Dickinson and Company has a dividend yield of 1.44% with a dividend per share of $3.64 and a payout ratio of 57.00%.

Becton Dickinson and Company has a Sell technical analysis rating based on Technical Indicators (ADX : 9.32, ATR14 : 4.19, CCI20 : -45.20, Chaikin Money Flow : -0.05, MACD : -5.24, Money Flow Index : 39.61, ROC : 0.65, RSI : 36.09, STOCH (14,3) : 59.98, STOCH RSI : 0.46, UO : 42.53, Williams %R : -40.02), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Becton Dickinson and Company in the last 12-months were: Richard Byrd (Sold 1 421 shares of value $353 261 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (61.54 %)
8 (61.54 %)
9 (64.29 %)
Moderate Buy
2 (15.38 %)
2 (15.38 %)
2 (14.29 %)
Hold
3 (23.08 %)
3 (23.08 %)
3 (21.43 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.58
Strong Buy
1.58
Strong Buy
1.54

Becton Dickinson and Company

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

CEO: Thomas E. Polen

Telephone: +1 201 847-6800

Address: 1 Becton Drive, Franklin Lakes 07417-1880, NJ, US

Number of employees: 72 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

51%49%

Bearish Bullish

57%43%

 

TipRanks News for BDX

Thu, 12 Oct 2023 05:55 GMT Becton Dickinson (BDX) Receives a Buy from DBS

- TipRanks. All rights reserved.

Mon, 07 Aug 2023 09:20 GMT Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Becton Dickinson (BDX) and Regeneron (REGN)

- TipRanks. All rights reserved.

Mon, 24 Jul 2023 11:35 GMT Becton Dickinson (BDX) Gets a Buy from Bank of America Securities

- TipRanks. All rights reserved.

News

Stocktwits